This inventor holds 2 USPTO granted patents and 8 published patent applications and 2 EPO patents. Top assignees: Mayo Foundation for Medical Education and Research, Iowa State University Research Foundation Inc.. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020-2025
Title: The Innovations of Stephen C Ekker
Introduction
Stephen C Ekker is a prominent inventor based in Rochester, MN (US). He has made significant contributions to the field of molecular biology, particularly in the area of gene editing and nucleic acid constructs. With a total of 2 patents, his work has paved the way for advancements in genetic research and applications.
Latest Patents
Stephen C Ekker's latest patents include innovative methods and materials for efficient targeted knock-in or gene replacement. These patents provide high precision and efficiency in generating targeted knock-ins and gene replacements. Additionally, he has developed methods and materials for assembling nucleic acid constructs, such as TALENs. These methods are designed to be rapid and flexible, making them accessible for various cloning scaffolds and achievable with standard molecular biology laboratory tools.
Career Highlights
Throughout his career, Stephen has worked with esteemed organizations such as the Mayo Foundation for Medical Education and Research and Iowa State University Research Foundation Inc. His contributions to these institutions have been instrumental in advancing research in genetics and molecular biology.
Collaborations
Stephen has collaborated with notable colleagues, including Karl J Clark and Maura McGrail. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Stephen C Ekker's work exemplifies the spirit of innovation in the field of molecular biology. His patents and collaborations continue to influence the landscape of genetic research, making significant strides in the accessibility and efficiency of gene editing technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile